Tumour Budding in Oral Squamous Cell Carcinoma: a Meta-analysis

Overview

Journal Br J Cancer

Specialty Oncology

Date 2017 Dec 1

PMID 29190636

Citations 74

Authors

Alhadi Almangush

Matti Pirinen

Ilkka Heikkinen

Antti A Makitie

Tuula Salo

Ilmo Leivo

Affiliations

Soon will be listed here.

Abstract

Background: Tumour budding has been reported as a promising prognostic marker in many cancers. This meta-analysis assessed the prognostic value of tumour budding in oral squamous cell carcinoma (OSCC).

Methods: We searched OvidMedline, PubMed, Scopus and Web of Science for articles that studied tumour budding in OSCC. We used reporting recommendations for tumour marker (REMARK) criteria to evaluate the quality of studies eligible for meta-analysis.

Results: A total of 16 studies evaluated the prognostic value of tumour budding in OSCC. The meta-analysis showed that tumour budding was significantly associated with lymph node metastasis (odds ratio=7.08, 95% CI=1.75-28.73), disease-free survival (hazard ratio=1.83, 95% CI=1.34-2.50) and overall survival (hazard ratio=1.88, 95% CI=1.25-2.82).

Conclusions: Tumour budding is a simple and reliable prognostic marker for OSCC. Evaluation of tumour budding could facilitate personalised management of OSCC.

Citing Articles

Multi-omics analysis to uncover the molecular basis of tumor budding in head and neck squamous cell carcinoma.

Ourailidis I, Stogbauer F, Zhou Y, Beck S, Romanovsky E, Eckert S NPJ Precis Oncol. 2025; 9(1):73.

PMID: 40082664 PMC: 11906922. DOI: 10.1038/s41698-025-00856-2.

Significance of Malic Enzyme 1 in Cancer: A Review.

Fujiwara-Tani R, Nakashima C, Ohmori H, Fujii K, Luo Y, Sasaki T Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996805 PMC: 11854147. DOI: 10.3390/cimb47020083.

Accumulating evidence from meta-analyses of prognostic studies on oral cancer: towards biomarker-driven patient selection.

Almangush A, Alabi R, Pirinen M, Makitie A, Leivo I BMC Cancer. 2024; 24(1):1517.

PMID: 39696123 PMC: 11658108. DOI: 10.1186/s12885-024-13317-z.

Tumor budding and lymphovascular invasion as prognostic factors in p16-positive oropharyngeal squamous cell carcinomas.

Stogbauer F, Wirth M, Lauterbach M, Wollenberg B, Schmidl B, Hoch C Br J Cancer. 2024; 132(2):212-221.

PMID: 39613843 PMC: 11747400. DOI: 10.1038/s41416-024-02912-3.

Tumour Budding in Oral Squamous Cell Carcinoma: A Narrative Review.

Jakkulwar S, Vagha S, Chaudhary M Cureus. 2024; 16(9):e69624.

PMID: 39429322 PMC: 11488996. DOI: 10.7759/cureus.69624.

References

Chen T, Wang C, Ko J, Yang T, Hsu C, Yeh K . The impact of perineural invasion and/or lymphovascular invasion on the survival of early-stage oral squamous cell carcinoma patients. Ann Surg Oncol. 2013; 20(7):2388-95. DOI: 10.1245/s10434-013-2870-4. View

Attramadal C, Kumar S, Boysen M, Dhakal H, Nesland J, Bryne M . Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas. Anticancer Res. 2015; 35(11):6111-20. View

Guolo A, Varin C . Random-effects meta-analysis: the number of studies matters. Stat Methods Med Res. 2015; 26(3):1500-1518. DOI: 10.1177/0962280215583568. View

Jensen D, Dabelsteen E, Specht L, Fiehn A, Therkildsen M, Jonson L . Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma. J Pathol. 2015; 236(4):505-16. DOI: 10.1002/path.4550. View

Almangush A, Karhunen M, Hautaniemi S, Salo T, Leivo I . Prognostic value of tumour budding in oesophageal cancer: a meta-analysis. Histopathology. 2015; 68(2):173-82. DOI: 10.1111/his.12781. View

Jensen D, Reibel J, Mackenzie I, Dabelsteen E . Single cell migration in oral squamous cell carcinoma - possible evidence of epithelial-mesenchymal transition in vivo. J Oral Pathol Med. 2015; 44(9):674-9. DOI: 10.1111/jop.12321. View

Almangush A, Leivo I, Siponen M, Sundquist E, Mroueh R, Makitie A . Evaluation of the budding and depth of invasion (BD) model in oral tongue cancer biopsies. Virchows Arch. 2017; 472(2):231-236. DOI: 10.1007/s00428-017-2212-1. View

Angadi P, Patil P, Hallikeri K, Mallapur M, Hallikerimath S, Kale A . Tumor budding is an independent prognostic factor for prediction of lymph node metastasis in oral squamous cell carcinoma. Int J Surg Pathol. 2015; 23(2):102-10. DOI: 10.1177/1066896914565022. View

Karamitopoulou E . Tumor budding cells, cancer stem cells and epithelial-mesenchymal transition-type cells in pancreatic cancer. Front Oncol. 2013; 2:209. PMC: 3539658. DOI: 10.3389/fonc.2012.00209. View

10.

Landau M, Hastings S, Foxwell T, Luketich J, Nason K, Davison J . Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma. Mod Pathol. 2014; 27(12):1578-89. PMC: 4209206. DOI: 10.1038/modpathol.2014.66. View

11.

Seki M, Sano T, Yokoo S, Oyama T . Tumour budding evaluated in biopsy specimens is a useful predictor of prognosis in patients with cN0 early stage oral squamous cell carcinoma. Histopathology. 2016; 70(6):869-879. DOI: 10.1111/his.13144. View

12.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

13.

Junior H, Rocha V, Leite C, de Aguiar M, Souza P, Horta M . Laminin-5 gamma 2 chain expression is associated with intensity of tumor budding and density of stromal myofibroblasts in oral squamous cell carcinoma. J Oral Pathol Med. 2013; 43(3):199-204. DOI: 10.1111/jop.12121. View

14.

Hori Y, Kubota A, Yokose T, Furukawa M, Matsushita T, Takita M . Predictive Significance of Tumor Depth and Budding for Late Lymph Node Metastases in Patients with Clinical N0 Early Oral Tongue Carcinoma. Head Neck Pathol. 2017; 11(4):477-486. PMC: 5677061. DOI: 10.1007/s12105-017-0814-1. View

15.

Kadota K, Yeh Y, Villena-Vargas J, Cherkassky L, Drill E, Sima C . Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma. Chest. 2015; 148(3):711-721. PMC: 4556124. DOI: 10.1378/chest.14-3005. View

16.

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

17.

Zhang P, Zhang L, Liu H, Zhao L, Li Y, Shen J . Clinicopathologic Characteristics and Prognosis of Tongue Squamous Cell Carcinoma in Patients with and without a History of Radiation for Nasopharyngeal Carcinoma: A Matched Case-Control Study. Cancer Res Treat. 2016; 49(3):695-705. PMC: 5512375. DOI: 10.4143/crt.2016.317. View

18.

Wang C, Huang H, Huang Z, Wang A, Chen X, Huang L . Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. J Oral Pathol Med. 2011; 40(7):545-51. PMC: 3135705. DOI: 10.1111/j.1600-0714.2011.01041.x. View

19.

Zlobec I, Lugli A . Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget. 2011; 1(7):651-61. PMC: 3248128. DOI: 10.18632/oncotarget.199. View

20.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View